New study aims to find the right sequence of powerful drugs for advanced breast cancer
Disease control
Not yet recruiting
This study looks at 40 adults with a common type of advanced breast cancer (HR+/HER2-) that has stopped responding to standard hormone therapy. Researchers want to find the best order to give two targeted drugs (called antibody-drug conjugates) to control the cancer longer and im…
Phase: PHASE4 • Sponsor: Yan Xue • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC